TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Novel Medic AB
Closing information (x1000 DKK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
17,895
|
23,123
|
28,532 |
| Financial expenses |
0
|
0
|
24 |
| Earnings before taxes |
5,619
|
6,444
|
17,433 |
| EBITDA |
7,288
|
7,493
|
17,924 |
| Total assets |
18,439
|
28,022
|
25,287 |
| Current assets |
12,463
|
22,159
|
20,316 |
| Current liabilities |
2,296
|
2,474
|
3,414 |
| Equity capital |
14,928
|
24,292
|
20,925 |
| - share capital |
32
|
34
|
33 |
| Employees (average) |
9
|
13
|
14 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
81.0%
|
86.7%
|
82.8% |
| Turnover per employee |
1,988
|
1,779
|
2,038 |
| Profit as a percentage of turnover |
31.4%
|
27.9%
|
61.1% |
| Return on assets (ROA) |
30.5%
|
23.0%
|
69.0% |
| Current ratio |
542.8%
|
895.7%
|
595.1% |
| Return on equity (ROE) |
37.6%
|
26.5%
|
83.3% |
| Change turnover |
-4,464
|
-5,555
|
7,109 |
| Change turnover % |
-20%
|
-19%
|
33% |
| Chg. No. of employees |
-4
|
-1
|
4 |
| Chg. No. of employees % |
-31%
|
-7%
|
40% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.